High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy.
(Q40978441)
scientific article published on January 1999
scientific article published on January 1999
Language:
Current Data About
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy.